Fig. 12
From: Nanobiotechnology boosts ferroptosis: opportunities and challenges
(reproduced from ref. [168] with permission. Copyright 2021, Springer Nature)
A Schematic representation of the synergistic antitumor effect of the ferroptosis inducer Fe3+ and the exosome inhibitor GW4869. B Tumor growth curves during treatment. G1, PBS; G2, anti-PD-L1; G3, HGF; G4, HGF+ anti-PD-L1. C Survival rates of different groups over time. D–F Quantitative analysis the proportion of CD8+ and CD4+ T cells in CD3+ T cells in the tumor-draining lymph node. G–L Quantitative analysis the proportion of GzmB+ cells, Ki67+ cells and Tim3+ cells in CD8+ and CD4+ T cells